Inhibition of neurogenic vasodilatation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide
- 1 November 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 85 (2) , 171-176
- https://doi.org/10.1016/0014-2999(82)90462-9
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Analgesic effect of antagonists of substance PBiochemical and Biophysical Research Communications, 1981
- A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulationNature, 1981
- Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitorActa Physiologica Scandinavica, 1981
- Chemical design of antagonists of substance PActa Physiologica Scandinavica, 1981
- Substance P in trigeminal nerve endings: Occurrence and releaseActa Physiologica Scandinavica, 1981
- Inhibition of antidromic and substance P‐induced vasodilatation by a substance P antagonistActa Physiologica Scandinavica, 1981
- Postocclusive cutaneous vasodilatation mediated by substance PNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Somatostatin selectively inhibits noradrenaline release from hypothalamic neuronesNature, 1980
- Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature, 1980
- Release of Substance P-like Immunoreactivity from the Dental PulpActa Physiologica Scandinavica, 1977